AMOXICLAV 625 MG TABLET USP 2 X `7

Product Description

Co-amoxiclav is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):

•  Acute bacterial sinusitis (adequately diagnosed)
•  Acute otitis media
•  Acute exacerbations of chronic bronchitis (adequately diagnosed)
•  Community acquired pneumonia
•  Cystitis
•  Pyelonephritis
•  Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
•  Bone and joint infections, in particular osteomyelitis.
• Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Broad-Spectrum Infection Control

AMOXICLAV 625 MG Tablet is an effective combination antibiotic used to treat a range of bacterial infections such as respiratory tract infections, urinary tract infections, and skin infections. The fusion of amoxicillin with clavulanic acid enhances its resistance to bacterial enzymes, making the therapy more robust and effective.


Prescription-Based Dosage and Safety

This medicine should only be taken as advised by a healthcare provider, adhering to prescription-only (POM) protocols. Dosage varies based on the condition and individual health needs. Regular intake as per scheduled times and completion of the full course is important to prevent antibiotic resistance and ensure complete recovery.


Optimal Storage and Shelf Life

For best results and to maintain potency, store AMOXICLAV 625 MG TABLETS below 25C, away from direct sunlight and humidity. Proper storage preserves the effectiveness of the medication throughout its shelf life and ensures patient safety during use.